We previously reported that G‐CSF receptor (G‐CSFR) antagonism can prevent inflammation‐induced neutrophilia and limit the progression of an experimental model of rheumatoid arthritis.26, 27. This evidence concerns the gene CSF3R and rheumatoid arthritis.